For the quarter ending 2025-06-30, HLVX had -$95,790K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation | 4,759 |
| Net loss | -11,327 |
| Amortization of operating lease right-of-use assets | 477 |
| Prepaid expenses and other current assets | -4,686 |
| Operating lease liabilities | -971 |
| Loss on disposal of property and equipment | -240 |
| Depreciation | 491 |
| Net accretion/amortization of premiums and discounts on marketable securities | -1,759 |
| Accounts payable, accrued expenses and other long-term liabilities (includes related party amounts of 0 and 3, respectively) | -10,103 |
| Net cash used in operating activities | -13,507 |
| Proceeds from sales or maturities of marketable securities | 35,000 |
| Purchases of marketable securities | 117,283 |
| Net cash used in investing activities | -82,283 |
| Net decrease in cash, cash equivalents and restricted cash | -95,790 |
HilleVax, Inc. (HLVX)
HilleVax, Inc. (HLVX)